Full Text View
Tabular View
No Study Results Posted
Related Studies
Rosuvastatin Pre-Treatment Influences the Risk of Coronary Intervention Study (TIPS-3)
The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2011 by University Hospital, Motol.
Recruitment status was  Recruiting
Study NCT01378715   Information provided by University Hospital, Motol

First Received on June 20, 2011.   No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Coronary Artery Disease
Additional conditions recognized in this trial
Coronary Disease
Myocardial Ischemia
More general conditions related to this trial
Arterial Occlusive Diseases
Arteriosclerosis
Cardiovascular Diseases
Heart Diseases
Vascular Diseases
Interventions listed in this trial
Rosuvastatin
More general drug interventions related to this trial
Anticholesteremic Agents
Antimetabolites
Enzyme Inhibitors
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypolipidemic Agents
Lipid Regulating Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
University Hospital, Motol


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services